Literature DB >> 14627800

Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa.

Alexandra M Levine, Shigetaka Shimodaira, Michael M C Lai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14627800     DOI： 10.1056/NEJM200311203492121

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  [Malignant lymphomas of the liver: new diagnostic algorithms].

Authors:  T Longerich; P Schirmacher; H P Dienes; H Stein; C Loddenkemper
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

Review 2.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

Review 3.  Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.

Authors:  Carlo Visco; Silvia Finotto
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Borrelia infection and risk of non-Hodgkin lymphoma.

Authors:  Claudia Schöllkopf; Mads Melbye; Lars Munksgaard; Karin Ekström Smedby; Klaus Rostgaard; Bengt Glimelius; Ellen T Chang; Göran Roos; Mads Hansen; Hans-Olov Adami; Henrik Hjalgrim
Journal:  Blood       Date:  2008-04-18       Impact factor: 22.113

5.  Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.

Authors:  Keigo Machida; Yasuteru Kondo; Jeffrey Y Huang; Yung-Chia Chen; Kevin T-H Cheng; Zhenyong Keck; Steven Foung; Jean Dubuisson; Vicky M-H Sung; Michael M C Lai
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

Review 6.  Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options.

Authors:  Gabriele Pozzato; Cesare Mazzaro; Luigino Dal Maso; Endri Mauro; Francesca Zorat; Giulia Moratelli; Pietro Bulian; Diego Serraino; Valter Gattei
Journal:  World J Hepatol       Date:  2016-01-18

Review 7.  Hepatitis C virus infection induced vasculitis.

Authors:  Patrice Cacoub; David Saadoun
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

8.  Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins.

Authors:  Keigo Machida; Kyoko Tsukiyama-Kohara; Satoshi Sekiguch; Eiji Seike; Shigenobu Tóne; Yukiko Hayashi; Yoshimi Tobita; Yuri Kasama; Masumi Shimizu; Hidemi Takahashi; Chyoji Taya; Hiromichi Yonekawa; Nobuyuki Tanaka; Michinori Kohara
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

Review 9.  Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.

Authors:  Luca Arcaini; Michele Merli; Stefano Volpetti; Sara Rattotti; Manuel Gotti; Francesco Zaja
Journal:  Clin Dev Immunol       Date:  2012-08-26

Review 10.  Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.

Authors:  Fabio Forghieri; Mario Luppi; Patrizia Barozzi; Rossana Maffei; Leonardo Potenza; Franco Narni; Roberto Marasca
Journal:  Clin Dev Immunol       Date:  2012-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.